Sign in

Lost your password?
(close)

Novartis Healthcare Philippines

Last updated: 01.06.2015

Address: 3/F Asian Reinsurance Building
Salcedo corner Gamboa Street
Legaspi Village, Makati City 1229
Philippines

Tel: +63 2 368 7777

Web: http://www.novartis.com.ph/

Company description

For more than half a century now, Novartis Healthcare has been active in the Philippines through local agents Sandoz (Philippines), Inc. and Ciba Geigy (Philippines), Inc., founded in 1964 and 1973, respectively. Novartis in the Philippines was incorporated in 1996, integrating Ciba Geigy and Sandoz Philippines, following the merger of the giant parent companies.

Novartis Healthcare Philippines, Inc. locally markets various quality pharmaceutical consumer products developed through years of research. Our mission is to discover, develop and successfully market innovative products to cure diseases, ease suffering, and enhance people’s quality of life.

Products and services

Novartis Healthcare Philippines is composed of two divisions:

The world-renowned Pharmaceuticals Division of Novartis provides a broad range of innovative medicines to patients, physicians and healthcare organizations. It develops and markets patent-protected prescription drugs for important health needs. Its product portfolio focuses on the following major therapeutic areas:

* Cardiovascular & Metabolism
* Oncology & Hematology
* Neuroscience & Ophthalmics
* Respiratory
* Immunology & Infectious Diseases
* Arthritis and Bone

Novartis Consumer Health Division provides self-medication products for the treatment and prevention of common illnesses and conditions, and the enhancement of overall health and well-being. One of the division’s biggest business units is the Novartis Consumer Heath Over The Counter, which aims to provide consumers with a constant flow of innovative health-enhancing brands. Its product portfolio includes the following:

* Cough
* Topical Nasal Preparation
* Antifungal
* Analgesics
* Oral Pharyngeal
* Allergy
* Gastrointestinal
* Smoking cessation
* Vasoprotectives

Interviews

Related

We use cookies to ensure that we give you the best experience on our site. For more info click here